Results 11 to 20 of about 353,671 (365)
Annals of Internal Medicine, 1998 The North American guidelines for pneumonia generally show agreement in both the Canadian and American approaches. However, much new data have appeared since the original recommendations, and revisions are needed. The general approach to empiric therapy that has been proposed in both the Canadian and American Thoracic Society documents does appear to ...
S. Stone
semanticscholar +15 more sources
Advances in community-acquired pneumonia [PDF]
Therapeutic Advances in Infectious Disease, 2020 Community-acquired pneumonia is one of the commonest and deadliest of the infectious diseases, yet our understanding of it remains relatively poor. The recently published American Thoracic Society and Infectious Diseases Society of America Community ...
Barbara Jones, Grant Waterer
doaj +4 more sources
Community-acquired pneumonia [PDF]
The Lancet, 2015 Community-acquired pneumonia causes great mortality and morbidity and high costs worldwide. Empirical selection of antibiotic treatment is the cornerstone of management of patients with pneumonia. To reduce the misuse of antibiotics, antibiotic resistance, and side-effects, an empirical, effective, and individualised antibiotic treatment is needed ...
Otavio T. Ranzani +2 more
+15 more sources
Community-Acquired Pneumonia [PDF]
New England Journal of Medicine, 2014 Community-acquired pneumonia is a commonly diagnosed illness in which no causative organism is identified in half the cases. Application of molecular diagnostic techniques has the potential to lead to more targeted therapy in the face of increasing antibiotic resistance.
Jonathan London +2 more
+21 more sources
Community-Acquired Pneumonia [PDF]
Paediatric Respiratory Reviews, 2006 Early identification of patients with severe community-acquired pneumonia (SCAP) who require ICU care is important as delayed transfer is associated with increased mortality. In such patients, aggressive diagnostic testing is warranted given the increased probability of detecting a pathogen resistant to usual empirical therapy.
Paulo José Cauduro Marostica +1 more
openaire +6 more sources
Annals of Gastroenterological Surgery, Volume 7, Issue 1, Page 81-90, January 2023., 2023 XELOXIRI neoadjuvant chemotherapy appears to be feasible and efficacious for patients with LARC. Although neoadjuvant XELOXIRI alone did not yield our expected pCR rate, the local recurrence rate, 3‐year DFS and measures of safety met current standards.
Chu Matsuda +16 more
wiley +1 more source
Bruton tyrosine kinase inhibitors in the management of Waldenström macroglobulinemia
American Journal of Hematology, Volume 98, Issue 2, Page 338-347, February 2023., 2023 Abstract Bruton tyrosine kinase (BTK) inhibitors have taken a central role in the management of patients with Waldenström macroglobulinemia and are the only agents approved by the Food and Drug Administration (FDA) to treat these patients. Although associated with high rates of durable responses, unmet needs with BTK inhibitor therapy include ...
Jorge J. Castillo +4 more
wiley +1 more source
The Bulletin of the Ecological Society of America, Volume 104, Issue 1, January 2023., 2023 Summary In response to the SARS‐CoV‐2 (Covid‐19) pandemic, multiple calls were made for the better use of various tools developed in many disparate academic disciplines. Included in these calls were claims that techniques used widely across ecological sciences could be better capitalized on, despite a rich and longstanding history of including ecology ...
Lewis J. Bartlett, Tyler J. Washburn
wiley +1 more source
A prediction rule to identify low-risk patients with community-acquired pneumonia.
New England Journal of Medicine, 1997 BACKGROUND There is considerable variability in rates of hospitalization of patients with community-acquired pneumonia, in part because of physicians' uncertainty in assessing the severity of illness at presentation.
M. Fine +8 more
semanticscholar +1 more source
Journal of Intensive Care, 2021 Objectives SARS-CoV-2 may cause acute lung injury, and secondary infections are thus relevant complications in patients with COVID-19 pneumonia. However, detailed information on community- and hospital-acquired infections among patients with COVID-19 ...
K. Søgaard +17 more
semanticscholar +1 more source